NOTICES
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
(Docket 63-91)
Foreign-Trade Zone 61, San Juan, Puerto Rico; Application for Subzone,
Searle
Pharmaceutical Plant, Caguas, Puerto Rico; Amendment to Application
Wednesday, August 26, 1992
Notice is hereby given that the application submitted by the Puerto Rico
Commercial and Farm Credit and Development Corporation, grantee of FTZ 61,
requesting special-purpose subzone status for the pharmaceutical products
manufacturing facilities of Searle & Company (Searle) (subsidiary of
Monsanto Co.) in Caguas, Puerto Rico (56 FR 56187, 11/1/91) has been
amended to modify the boundaries of the proposed site and to include
additional finished products within the scope of its manufacturing request.
The original application listed the following products that would be
manufactured under zone procedures: cardiovascular, antihistamine,
antiasthmatic, hormonal, antimicrobial, anticholinergic, antipsychotic,
gastrointestinal, and antidiarrheal products as well as anabolic steroids.
The amendment adds the following to the list of products that could be
manufactured under zone procedures: Fertility, antiinfective,
antibacterial, antitumor, immunologic, antiinflammatory, anti-arthritic,
respiratory, alimentary, analgesic, anti-allergic, chemotherapeutic,
anesthetic, and vitamin products, as well as drugs affecting the central
nervous system, including anticonvulsants, hypnotics and sedatives.
The amendment also modifies the description of the site to include within
the proposed subzone boundaries a local road that the Municipality of
Caguas has transferred to the company in exchange for other property. The
application remains otherwise unchanged.
The comment period is reopened until October 13, 1992.
Dated: August 20, 1992.
Dennis Puccinelli,
Acting Executive Secretary.
(FR Doc. 92-20475 Filed 8-25-92; 8:45 am)